1 | Acetate | 11c-acetate [98] 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; | - |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
2 | Acetylcarnitine | Acetylcarnitine [1] Acetylcarnitine; | - |
- |
- |
002 [3] 2 , 265, 298 💬 |
3 | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - |
- |
- |
002 [3] 2 , 6 , 46 💬 |
4 | Albumin human | - | [2] D02792 D02792
D05424 D05424 💬 |
- |
- |
002 [3] 2 , 78, 96 💬 |
5 | Aldesleukin | Aldesleukin [3] Aldesleukin; Interleukin-2 (aldesleukin).; Low-dose aldesleukin (proleukin®); | [1] D00748 D00748 💬 |
[3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
002 [5] 2 , 49, 65, 96, 97 💬 |
6 | Ampicillin | - | [3] D00204 D00204
D01251 D01251
D02119 D02119 💬 |
- |
- |
002 [5] 2 , 6 , 13, 84, 299 💬 |
7 | Anakinra | Anakinra [8] Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra / kineret; Anakinra and peg stnf-r1; Kineret® (anakinra); Kineret® or anakinra; Response to anakinra associated with methotrexate; | [1] D02934 D02934 💬 |
[2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [19] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
8 | Arimoclomol | Arimoclomol [4] Arimoclomol; Arimoclomol (hard gelatine capsule); Arimoclomol (hpmc capsule); Arimoclomol citrate; | [1] D11374 D11374 💬 |
- |
- |
002 [3] 2 , 15, 19 💬 |
9 | Arundic acid | Arundic acid [1] Arundic acid; | [1] D06296 D06296 💬 |
- |
- |
002 [1] 2 💬 |
10 | Atropine | Atropine [2] Atropine; Scopolamine, atropine, edaravone and dexmedetomidine; | [5] D00113 D00113
D01077 D01077
D02069 D02069
D03011 D03011
D03814 D03814 💬 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
002 [1] 2 💬 |
11 | Baclofen | Aert, (r)-baclofen [20] Aert, (r)-baclofen; Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; Baclofen; Baclofen 20 mg; Baclofen er capsules (grs) 10 mg; Baclofen er capsules (grs) 20 mg; Baclofen er capsules (grs) 30mg; Baclofen er capsules (grs) 40mg; Baclofen er capsules (grs) 50 mg; Baclofen ir; Baclofen tablets usp; Baclofen tablets usp 10 mg; Encapsulated baclofen 20 mg; Rs-baclofen; | [1] D00241 D00241 💬 |
[2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 [5] 2 , 10, 13, 18, 149 💬 |
12 | Basiliximab | Basiliximab [1] Basiliximab; | [1] D03058 D03058 💬 |
[1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [7] 2 , 50, 65, 66, 97, 222, 228 💬 |
13 | Betamethasone | Betamethasone [6] Betamethasone; Betamethasone acibutate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Intra-articular compound betamethasone; Intraarticular betamethasone; Phosphate and betamethasone acetate, 2 ml.; | [7] D00244 D00244
D00972 D00972
D01357 D01357
D01402 D01402
D01637 D01637
D02032 D02032
D02286 D02286 💬 |
[1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [6] 2 , 28, 46, 90, 96, 235 💬 |
14 | Biotin | Biotin [7] Biotin; Biotina; D-biotin; D-biotina; High doses of thiamine y biotin; Moderate doses of thiamine y biotin; Prebiotics (prebiotin prebiotic fiber stick pac); | [1] D00029 D00029 💬 |
- |
- |
002 [5] 2 , 8 , 10, 13, 20 💬 |
15 | Bosutinib | Bosutinib [2] Bosutinib; Bosutinib (anhydrous); | [1] D03252 D03252 💬 |
[2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
002 [2] 2 , 67 💬 |
16 | Botulinum toxin type A | Botulinum toxin type a [6] Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Botulinum toxin type a 200u; Botulinum toxin type a 300u; Botulinum toxin type a infiltrations; Clostridium botulinum toxin type a; | [1] D00783 D00783 💬 |
[1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [13] 2 , 5 , 6 , 7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬 |
17 | Botulinum Toxin Type B | Botulinum toxin type b [3] Botulinum toxin type b; Botulinum toxin type b (2500 units / vial); Botulinum toxin type b (myobloc); | [1] D02735 D02735 💬 |
[1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [3] 2 , 6 , 51 💬 |
18 | Butylphthalide | Butylphthalide [2] Butylphthalide; Dl-3-n-butylphthalide (nbp); | - |
- |
- |
002 [4] 2 , 6 , 18, 22 💬 |
19 | Caffeine | Caffeine [6] Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; | [2] D00528 D00528
D01453 D01453 💬 |
[11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
20 | Cannabidiol | Avcn583601 (3% cannabidiol cream) [11] Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | [1] D10915 D10915 💬 |
[2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 [19] 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
21 | Capsaicin | Capsaicin [5] Capsaicin; Capsaicin challenge; Capsaicin vapor; Other: challenge agent: capsaicin; Qutenza (8% capsaicin); | [1] D00250 D00250 💬 |
[1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [5] 2 , 6 , 19, 86, 226 💬 |
22 | Carbidopa | Accordion pill carbidopa/levodopa [85] Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Anhydrous carbidopa; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa; Carbidopa (fu); Carbidopa 20 mg; Carbidopa 200mg oral dose; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa anidra; Carbidopa fu; Carbidopa inn; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-4'-monophosphate; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Carbidopamonohydraat; Combination product: l-dopa 70mg/carbidopa 7mg; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Entacapone and carbidopa; Foscarbidopa; Foscarbidopa and foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Ir cd-ld (carbidopa-levodopa) tablets; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; Xp21279 and carbidopa (experimental); | [1] D00558 D00558 💬 |
[1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
23 | Carbonate ion | - | - |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
24 | Ceftriaxone | Ceftriaxone [1] Ceftriaxone; | [2] D00924 D00924
D07659 D07659 💬 |
- |
- |
002 [3] 2 , 6 , 97 💬 |
25 | Celecoxib | Celebra (celecoxib) [8] Celebra (celecoxib); Celecoxib; Celecoxib (celebrex); Celecoxib 200 milligrams; Celecoxib 200mg capsule; Celecoxib 400 milligrams; Celecoxib, celebrex®; Fixed dose combination ciprofloxacin/celecoxib; | [1] D00567 D00567 💬 |
[1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [9] 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
26 | Cimetidine | Cimetidine [2] Cimetidine; Cimetidine plus dexpramipexole; | [2] D00295 D00295
D03503 D03503 💬 |
[1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
002 [1] 2 💬 |
27 | Ciprofloxacin | Cipro (ciprofloxacin, bayq3939) [17] Cipro (ciprofloxacin, bayq3939); Ciprofloxacin; Ciprofloxacin (bayq3939) dry powder for inhalation; Ciprofloxacin (cipro inhale, bayq3939); Ciprofloxacin (cipro, bayq3939); Ciprofloxacin (ciproxin); Ciprofloxacin dispersion for inhalation; Ciprofloxacin dpi; Ciprofloxacin dpi (bayq3939); Ciprofloxacin for inhalation; Ciprofloxacin hydrochloride; Ciprofloxacin hydrochloride monohydrate; Ciprofloxacin inhale; Fixed dose combination ciprofloxacin/celecoxib; Oral ciprofloxacin; Oral ciprofloxacin plus inhaled colistin; Po ciprofloxacin; | [2] D00186 D00186
D02216 D02216 💬 |
- |
- |
002 [5] 2 , 60, 96, 97, 299 💬 |
28 | Clenbuterol | Clenbuterol [3] Clenbuterol; Clenbuterol hcl; Clenbuterol hydrochloride; | [1] D07713 D07713 💬 |
[1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 [5] 1 , 2 , 6 , 13, 256 💬 |
29 | Colchicine | Colchicine [5] Colchicine; Colchicine 1 mg oral tablet; Colchicine sprinkle capsules; Diagnostic test: colchicine level measurement; Other: colchicine cessation; | [1] D00570 D00570 💬 |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 [7] 2 , 42, 46, 56, 93, 210, 266 💬 |
30 | Copper | Copper [5] Copper; Copper (64cu) chloride; Copper histidinate; Copper histidine; Zinc and copper; | - |
- |
- |
002 [4] 2 , 169, 170, 171 💬 |
31 | Corticotropin | Adrenocorticotropin hormone [8] Adrenocorticotropin hormone; Corticotropin; Corticotropin-releasing hormone; H.p. acthar gel (repository corticotropin injection); Other: corticotropin releasing hormone (crh); Ovine corticotropin-releasing hormone (ocrh); Repository corticotropin injection; Repository corticotropin injection -treatment extension; | [1] D00146 D00146 💬 |
[1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [13] 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬 |
32 | Creatine | Creatine [4] Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
33 | Creatinine | Creatinine [1] Creatinine; | [1] D03600 D03600 💬 |
- |
- |
002 [4] 2 , 46, 60, 70 💬 |
34 | Cromoglicic acid | - | [2] D00526 D00526
D07753 D07753 💬 |
- |
- |
002 [3] 2 , 85, 98 💬 |
35 | Curcumin | Bio-enhanced curcumin soft gelatin capsule [6] Bio-enhanced curcumin soft gelatin capsule; Curcumin; Curcumin (longvida™); Curcumin supplement; Liposomed polyphenols resveratrol and curcumin; Nanocurcumin; | - |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
36 | Darunavir | Darunavir [1] Darunavir; | [1] D03656 D03656 💬 |
- |
- |
002 [1] 2 💬 |
37 | Deferiprone | Deferiprone [11] Deferiprone; Deferiprone (ferriprox); Deferiprone 20mg; Deferiprone 30mg; Deferiprone 600 mg delayed release tablet; Deferiprone 80 mg/ml oral solution; Deferiprone 80 mg/ml oral solution (ferriprox); Deferiprone dr; Deferiprone oral solution; Deferiprone treated; Ferrprox (deferiprone); | [1] D07416 D07416 💬 |
- |
- |
002 [6] 2 , 6 , 18, 120, 122, 233 💬 |
38 | Dexmedetomidine | Dexmedetomidine [10] Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; | [2] D00514 D00514
D01205 D01205 💬 |
[3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
39 | Dexpramipexole | Cimetidine plus dexpramipexole [6] Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Dexpramipexole dihydrochloride; | [1] D09886 D09886 💬 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [1] 2 💬 |
40 | Dextran | Device: dextran sulfate adsorption [7] Device: dextran sulfate adsorption; Dextran; Dextran 1 for injection; Dextran sodium sulfur salt 5, mw 5 kda. a type of low molecular weight dextran sulfate (lmw-ds); Dextran sulfate sodium; Iron dextran; Iron(iii)- hydroxide dextran complex; | [1] D00060 D00060 💬 |
- |
- |
002 [5] 2 , 62, 79, 96, 97 💬 |
41 | Dextromethorphan | Dextromethorphan [10] Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | [3] D00848 D00848
D03742 D03742
D03744 D03744 💬 |
[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
42 | Dextrose, unspecified form | - | - |
- |
- |
002 [18] 2 , 6 , 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
43 | Dolutegravir | Dolutegravir [2] Dolutegravir; Dolutegravir 50 mg; | [1] D10066 D10066 💬 |
- |
- |
002 [2] 2 , 265 💬 |
44 | Dronabinol | Cannabidiol / dronabinol capsule 5 mg+2,5 mg [5] Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol; Dronabinol 25 mg/ml, oral drops; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg; | [1] D00306 D00306 💬 |
[2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 [7] 2 , 8 , 13, 46, 96, 271, 298 💬 |
45 | Dutasteride | Dutasteride [2] Dutasteride; Dutasteride 0.5 mg; | [1] D03820 D03820 💬 |
[2] SRD5A1, SRD5A2 💬 |
Prostate cancer [2] Prostate cancer, Steroid hormone biosynthesis |
001 [2] 1 , 2 💬 |
46 | Edaravone | Edaravone [2] Edaravone; Scopolamine, atropine, edaravone and dexmedetomidine; | [1] D01552 D01552 💬 |
- |
- |
002 [2] 2 , 22 💬 |
47 | Eperisone | Eperisone [1] Eperisone; | [2] D01671 D01671
D07898 D07898 💬 |
- |
- |
002 [1] 2 💬 |
48 | EPI-589 | Epi-589 [1] Epi-589; | - |
- |
- |
002 [2] 2 , 6 💬 |
49 | Erythropoietin | Erythropoietin [4] Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); | [1] D03231 D03231 💬 |
[1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [10] 2 , 6 , 13, 18, 22, 46, 47, 70, 95, 96 💬 |
50 | Escitalopram | Escitalopram [4] Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | [3] D02567 D02567
D07704 D07704
D07913 D07913 💬 |
[1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
002 [3] 2 , 6 , 13 💬 |
51 | Esketamine | Esketamine [2] Esketamine; Esketamine hydrochloride; | [1] D07283 D07283 💬 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [3] 2 , 4 , 70 💬 |
52 | Ezogabine | Ezogabine [4] Ezogabine; Ezogabine (us only); Ezogabine/retigabine; Retigabine/ezogabine; | [1] D09569 D09569 💬 |
[5] KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
002 [2] 2 , 144 💬 |
53 | Fasudil | Fasudil [2] Fasudil; Fasudil hydrochloride; | [1] D07941 D07941 💬 |
[2] ROCK1, ROCK2 💬 |
Axon guidance [22] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 51 💬 |
54 | Febuxostat | Febuxostat [1] Febuxostat; | [1] D01206 D01206 💬 |
[1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 [3] 2 , 6 , 13 💬 |
55 | Fig | Fig [1] Fig; | - |
- |
- |
002 [1] 2 💬 |
56 | Filgrastim | Ep2006 (filgrastim) [7] Ep2006 (filgrastim); Filgrastim; Filgrastim (g-csf); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Pegfilgrastim; | [1] D03235 D03235 💬 |
[1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [33] 2 , 6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
57 | Glatiramer | 20mg/0.5ml glatiramer acetate [29] 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 40 mg glatiramer acetato; Cyclophosphamide/glatiramer acetate; Experimental glatiramer acetate; Glatiramer; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Glatiramer acetato; Glatiramero acetato; Human interferon beta-1a and glatiramer acetate; Procedure: warm compress prior to injection of glatiramer acetate; | [1] D04318 D04318 💬 |
[20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [4] 2 , 13, 96, 156 💬 |
58 | Gold | Gold [7] Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
59 | Guanabenz | Guanabenz [2] Guanabenz; Guanabenz acetato; | [1] D04375 D04375 💬 |
[3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [2] 2 , 13 💬 |
60 | Human interleukin-2 | Anti-human interleukin-23 monoclonal antibody [3] Anti-human interleukin-23 monoclonal antibody; Human interleukin-2; Recombinant human interleukin-2 (rhil-2); | - |
- |
- |
002 [17] 2 , 13, 35, 46, 49, 51, 53, 55, 56, 60, 63, 65, 95, 96, 97, 162, 271 💬 |
61 | Human Umbilical Cord Mesenchymal Stem Cells | Human umbilical cord mesenchymal stem cells [1] Human umbilical cord mesenchymal stem cells; | - |
- |
- |
002 [12] 2 , 13, 36, 46, 49, 51, 60, 96, 97, 113, 274, 284 💬 |
62 | Ibudilast | Ibudilast [1] Ibudilast; | [1] D01385 D01385 💬 |
[8] CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 |
Apelin signaling pathway [16] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 13 💬 |
63 | Inosine | 1) inosine 5'-monophosphate [2] 1) inosine 5'-monophosphate; Inosine; | [1] D00054 D00054 💬 |
- |
- |
002 [5] 2 , 6 , 13, 17, 85 💬 |
64 | Iodide I-123 | - | - |
- |
- |
002 [2] 2 , 6 💬 |
65 | Ioflupane I-123 | - | [1] D10014 D10014 💬 |
- |
- |
002 [4] 2 , 5 , 6 , 17 💬 |
66 | Ketamine | Esketamine [6] Esketamine; Esketamine hydrochloride; Ketamine; Multi-modal pain management [intravenous ketamine]; S-ketamine; S-ketamine & midazolam; | [2] D00711 D00711
D08098 D08098 💬 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 13, 70, 113, 156, 215 💬 |
67 | Lacosamide | Lacosamide [1] Lacosamide; | [1] D07299 D07299 💬 |
[2] SCN3A, SCN9A 💬 |
Taste transduction [1] Taste transduction |
002 [3] 2 , 46, 149 💬 |
68 | Lactose | 2'-fucosyllactose [4] 2'-fucosyllactose; Lactose; Lactose in water; Lactose monohydrate; | [2] D00046 D00046
D03226 D03226 💬 |
- |
- |
002 [6] 2 , 6 , 13, 97, 228, 310 💬 |
69 | Lenograstim | Granocyte - 34 million iu (lenograstim rhug-csf) [3] Granocyte - 34 million iu (lenograstim rhug-csf); Granocyte lenograstim; Lenograstim; | [1] D03247 D03247 💬 |
[1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [7] 2 , 13, 16, 18, 19, 57, 65 💬 |
70 | Leuprolide | Depot leuprolide acetate 3.75 mg [11] Depot leuprolide acetate 3.75 mg; Leuprolide; Leuprolide (gnrh agonists); Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); | [2] D00989 D00989
D08113 D08113 💬 |
[1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 [5] 1 , 2 , 3 , 51, 76 💬 |
71 | Levetiracetam | Levetiracetam [1] Levetiracetam; | [1] D00709 D00709 💬 |
[1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
002 [4] 2 , 4 , 6 , 13 💬 |
72 | Levodopa | Accordion pill carbidopa/levodopa [111] Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Behavioral: levodopa or acupuncture; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa levodopa; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: levodopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Foscarbidopa and foslevodopa; Foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Intravenous levodopa; Ir cd-ld (carbidopa-levodopa) tablets; Iv levodopa; Levodopa; Levodopa (dc.it) (fu); Levodopa (delivered intravenously); Levodopa (drug), intraduodenal administration; Levodopa (l-dopa); Levodopa (l-dopa) + standard care; Levodopa / benserazid; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa 100 mg a cap; Levodopa 125 mg a cap; Levodopa 150 mg a cap; Levodopa 25mg/100mg; Levodopa 75 mg a cap; Levodopa acute challenge; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa and decarboxylase inhibitor; Levodopa and domperidone; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa cr (controlled release); Levodopa cyclops; Levodopa dc.it fu; Levodopa dispersible; Levodopa infusion; Levodopa inn; Levodopa mr; Levodopa powder for inhalation; Levodopa tablet; Levodopa test; Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa, decarboxylase inhibitor and comt inhibitor; Levodopa-4'-monophosphate; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; Levodopa/benzeraside; Levodopa/benzerazide; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Levodopa/ddci; Levodopa/dopa decarboxylase inhibitor; Melevodopa; Melevodopa and decarboxylase inhibitor; Nacom levodopa+cardidopa; Nd0612 (levodopa/carbidopa solution); Oral levodopa and carbidopa; Oral levodopa/carbidopa; Rasagiline mesylate with levodopa; Safinamide + levodopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Tvp-1012 (1 mg/day) with levodopa; Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; | [1] D00059 D00059 💬 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
73 | Levosimendan | Levosimendan [2] Levosimendan; Oral levosimendan; | [1] D04720 D04720 💬 |
[2] PDE3A, PDE3B 💬 |
Apelin signaling pathway [11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [1] 2 💬 |
74 | Lipoic acid | Alpha lipoic acid [9] Alpha lipoic acid; Alpha-lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Lipoic acid group; Oral lipoic acid (la); R lipoic acid; | [2] D00048 D00048
D00086 D00086 💬 |
- |
- |
002 [5] 2 , 5 , 13, 14, 20 💬 |
75 | Lithium carbonate | Lithium carbonate [1] Lithium carbonate; | [1] D00801 D00801 💬 |
- |
- |
002 [6] 2 , 13, 17, 18, 19, 127 💬 |
76 | Lithium citrate | Lithium citrate [1] Lithium citrate; | [1] D04749 D04749 💬 |
- |
- |
002 [5] 2 , 5 , 6 , 7 , 8 💬 |
77 | Lunasine | - | - |
- |
- |
002 [1] 2 💬 |
78 | Masitinib | Masitinib [12] Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; | [1] D10229 D10229 💬 |
[1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
79 | Mecobalamin | E0302 (mecobalamin) [2] E0302 (mecobalamin); Mecobalamin; | [1] D03246 D03246 💬 |
- |
- |
002 [1] 2 💬 |
80 | Medical Cannabis | - | - |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
81 | Memantine | Memantine [5] Memantine; Memantine (drug); Memantine (ebixa); Memantine hydrochloride; Memantine hydrochloride oral solution; | [2] D04905 D04905
D08174 D08174 💬 |
[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [7] 2 , 6 , 8 , 13, 49, 127, 205 💬 |
82 | Metformin | 750 mg metformin and 7.5 g l-citrulline daily p.o. [21] 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; | [2] D00944 D00944
D04966 D04966 💬 |
[2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
83 | Methamidophos | - | - |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
84 | Methylprednisolone | Administration of rituximab and methylprednisolone [35] Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; | [6] D00407 D00407
D00751 D00751
D00979 D00979
D05000 D05000
D05001 D05001
D05002 D05002 💬 |
[1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
85 | Mexiletine | Mexiletine [1] Mexiletine; | [2] D00639 D00639
D08215 D08215 💬 |
[5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
001 [5] 1 , 2 , 10, 113, 114 💬 |
86 | Midazolam | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) [7] Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; | [3] D00550 D00550
D00696 D00696
D05028 D05028 💬 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
87 | Minocycline | Combination of minocycline and mtx or mtx alone [8] Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; | [2] D00850 D00850
D05045 D05045 💬 |
- |
- |
002 [14] 2 , 6 , 8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
88 | Moxifloxacin | Avelox- moxifloxacin [6] Avelox- moxifloxacin; Moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride; Moxifloxacin infusion; Moxifloxacina cloridrato; | [2] D00874 D00874
D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
89 | Mycophenolate mofetil | Azathioprine or mycophenolate mofetil [19] Azathioprine or mycophenolate mofetil; Cellcept (mycophenolate mofetil); Cyclosporine combine with mycophenolate mofetil; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil (mmf); Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Mycophenolate mofetil [cellcept]; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil plus lower dose of prednisone; Mycophenolate mofetil(mmf); Mycophenolate mofetil, low dose steroid; Mycophenolate mofetil,methotrexate; Prednisolone and mycophenolate mofetil; Prednisone and mycophenolate mofetil; Prednisone, ciclosporin and mycophenolate mofetil; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); | [3] D00752 D00752
D05094 D05094
D05095 D05095 💬 |
[2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
90 | Mycophenolic acid | Mycophenolic acid [2] Mycophenolic acid; Mycophenolic acid mofetil; | [1] D05096 D05096 💬 |
[2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
91 | Nicotinamide | Eh301 (nicotinamide riboside/pterostilbene) [3] Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide; Nicotinamide riboside; | [1] D00036 D00036 💬 |
- |
- |
002 [9] 2 , 5 , 6 , 13, 18, 49, 67, 162, 191 💬 |
92 | Nicotinamide riboside | Eh301 (nicotinamide riboside/pterostilbene) [2] Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide riboside; | - |
- |
- |
002 [4] 2 , 6 , 18, 191 💬 |
93 | Olanzapine | Olanzapine [1] Olanzapine; | [2] D00454 D00454
D06623 D06623 💬 |
[11] ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 |
AMPK signaling pathway [16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 8 💬 |
94 | Ozanezumab | Ozanezumab [1] Ozanezumab; | [1] D10331 D10331 💬 |
[1] RTN4 💬 |
Alzheimer disease [1] Alzheimer disease |
002 [1] 2 💬 |
95 | Palmidrol | - | [1] D08328 D08328 💬 |
- |
- |
002 [1] 2 💬 |
96 | Perampanel | 2 mg perampanel [3] 2 mg perampanel; 4 mg perampanel; Perampanel; | [1] D08964 D08964 💬 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [3] 2 , 6 , 144 💬 |
97 | Phenylbutyric acid | - | [1] D05868 D05868 💬 |
- |
- |
002 [12] 2 , 3 , 6 , 8 , 15, 93, 94, 231, 244, 251, 297, 299 💬 |
98 | Phosphate ion | - | - |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
99 | Pimozide | Pimozide [4] Pimozide; Pimozide 2 mg per day; Pimozide 2mg/day (current) or 4 mg/day (study initiation); Pimozide 4 mg per day; | [1] D00560 D00560 💬 |
[2] DRD2, DRD3 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [1] 2 💬 |
100 | Pioglitazone | Actos (pioglitazone) [6] Actos (pioglitazone); Pioglitazone; Pioglitazone 15 mg; Pioglitazone and tretinoin; Pioglitazone or metformin; Tretinoin and pioglitazone hcl; | [2] D00945 D00945
D08378 D08378 💬 |
[1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
101 | Pleconaril | Pleconaril [1] Pleconaril; | [1] D05528 D05528 💬 |
- |
- |
002 [1] 2 💬 |
102 | Pramipexole | Cimetidine plus dexpramipexole [28] Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Dexpramipexole dihydrochloride; Dopamine agonists (pramipexole, ropirinole); Mirapex (pramipexole); P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Pramipexole; Pramipexole 0.125 mg tablets; Pramipexole 0.5 mg tablets; Pramipexole dihydrochloride; Pramipexole dihydrochloride extended-release tablets; Pramipexole dihydrochloride monohydrate; Pramipexole dihydrochloride monohydrate extended release; Pramipexole er; Pramipexole extended release; Pramipexole extended release tablet; Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole); Pramipexole immediate release; Pramipexole immediate release tablet; Pramipexole ir; Pramipexole or ropinirole; Pramipexole sr; Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride); R(+) pramipexole dihydrochloride monohydrate; | [2] D00559 D00559
D05575 D05575 💬 |
[3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [2] 2 , 6 💬 |
103 | Prednisone | 0 mg prednisone [73] 0 mg prednisone; 5 mg prednisone; 5-aminosalicylic acid(5-asa) and/or prednisone; Adalimumab, plus prednisone; Azathioprine/prednisone; Chinese herb prescription granule plus prednisone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Enalapril valsartan methylprednisone; Glucocorticoid (prednisone or prednisolone); Granulocyte-colony stimulating factor (g-csf) and prednisone; Hormone (prednisone); Hydroxychloroquine + prednisone; Ir prednisone; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Methylprednisone; Mr prednisone; Mycophenolate mofetil plus lower dose of prednisone; Oral prednisone; Oral prednisone 5mg; Other: prednisone; Over encapsulated prednisone; Prednisolone/prednisone; Prednisone; Prednisone (and methylprednisolone); Prednisone + inhibace/cozaar; Prednisone - azathioprine; Prednisone 0,5 mg/kg orally on alternate days; Prednisone 1 mg; Prednisone 15 mg; Prednisone 2 mg; Prednisone 3 mg; Prednisone 4 mg; Prednisone 5 mg; Prednisone 5 mg tablets; Prednisone 7.5 mg; Prednisone acetate; Prednisone acetate tablets; Prednisone alone; Prednisone and belimumab; Prednisone and cyclophosphamide; Prednisone and mycophenolate mofetil; Prednisone and ustekinumab treatment; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone capsules; Prednisone discontinuation; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Prednisone, ciclosporin and mycophenolate mofetil; Prednisone, cyclophosphamide; Prednisone, fk506, mmf; Prednisone, low dose rituximab; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Procedure: thymectomy plus prednisone; Rayos (delayed-release prednisone); Sotatercept with prednisone boost; Tacrolimus combined with prednisone; Thalidomide, cyclophosphamide and prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Ursodeoxycholic acid+low dose glucocorticoid(prednisone); | [1] D00473 D00473 💬 |
[1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
104 | Pridopidine | Pridopidine [3] Pridopidine; Pridopidine (90 mg); Pridopidine hydrochloride; | [1] D09953 D09953 💬 |
[1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [3] 2 , 6 , 8 💬 |
105 | Pyrimethamine | Fansidar (pyrimethamine and sulfadoxine) [2] Fansidar (pyrimethamine and sulfadoxine); Pyrimethamine; | [1] D00488 D00488 💬 |
- |
- |
002 [10] 2 , 4 , 6 , 19, 46, 51, 65, 96, 97, 265 💬 |
106 | Quinidine | Dextromethorphan hbr and quinidine sulfate [7] Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Quinidine; Quinidine sulfate; | [4] D00642 D00642
D00643 D00643
D02272 D02272
D08458 D08458 💬 |
[5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 [3] 2 , 8 , 13 💬 |
107 | Rabeprazole | Rabeprazole [1] Rabeprazole; | [2] D00724 D00724
D08463 D08463 💬 |
[2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
002 [2] 2 , 51 💬 |
108 | Ranolazine | Ranolazine [7] Ranolazine; Ranolazine 1000 mg; Ranolazine 1000 mg pr tablets; Ranolazine 500 mg; Ranolazine 500 mg pr tablets; Ranolazine 750 mg pr tablets; Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die; | [2] D05700 D05700
D05701 D05701 💬 |
- |
- |
002 [6] 2 , 58, 86, 96, 113, 114 💬 |
109 | Rasagiline | 1.0 mg rasagiline mesylate [16] 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesilate; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets; | [3] D02562 D02562
D08469 D08469
D10829 D10829 💬 |
[1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [6] 2 , 5 , 6 , 13, 17, 66 💬 |
110 | Ravulizumab | Ravulizumab [1] Ravulizumab; | [1] D11054 D11054 💬 |
[1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 [5] 2 , 11, 13, 62, 109 💬 |
111 | Reldesemtiv | Reldesemtiv [3] Reldesemtiv; Reldesemtiv 150 mg; Reldesemtiv 450 mg; | [1] D11363 D11363 💬 |
[1] TNNC2 💬 |
Calcium signaling pathway [1] Calcium signaling pathway |
002 [2] 2 , 3 💬 |
112 | Resveratrol | Liposomed polyphenols resveratrol and curcumin [2] Liposomed polyphenols resveratrol and curcumin; Resveratrol; | - |
- |
- |
002 [6] 2 , 8 , 18, 89, 113, 299 💬 |
113 | Ribavirin | Ribavirin [1] Ribavirin; | [1] D00423 D00423 💬 |
- |
- |
002 [2] 2 , 96 💬 |
114 | Riluzole | Plasma from healthy young people treatment + riluzole [8] Plasma from healthy young people treatment + riluzole; Riluzole; Riluzole (100 mg); Riluzole 50 mg; Riluzole 50 mg (part b); Riluzole oral soluble film; Riluzole oral soluble film (rosf) 50 mg; Riluzole pmcs; | [1] D00775 D00775 💬 |
[14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [8] 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
115 | Ritonavir | Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) [10] Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis); Atazanavir/ritonavir; Lopinavir/ritonavir; Lopinavir/ritonavir + nevirapine; Lopinavir/ritonavir + zidovudine + lamivudine; Monotherapy (lopinavir/ritonavir); Monotherapy (lopinavir/ritonavir) + abc/3tc; Ritonavir; Ritonavir (norvir); Saquinavir and ritonavir; | [1] D00427 D00427 💬 |
- |
- |
002 [3] 2 , 86, 265 💬 |
116 | Ropinirole | Hp-3000 (ropinirole hydrochloride patch) [27] Hp-3000 (ropinirole hydrochloride patch); Hp-3000(ropinirole hydrochloride patch); Pramipexole or ropinirole; Ropinirole; Ropinirole (as hydrochloride); Ropinirole controlled-release (requip cr) for rls; Ropinirole cr 2mg tablet; Ropinirole cr 8mg tablet; Ropinirole hydrochloride; Ropinirole hydrochloride extended-release tablet; Ropinirole hydrochloride extended-release tablet placebo; Ropinirole hydrochloride prolonged release; Ropinirole immediate release; Ropinirole implant; Ropinirole ir; Ropinirole ir tablets; Ropinirole monotherapy; Ropinirole oral product; Ropinirole pr; Ropinirole pr, 2mg; Ropinirole pr/xr; Ropinirole pr/xr tablets; Ropinirole prolonged release; Ropinirole prolonged release/extended release(pr/xr); Ropinirole xl; Ropinirole xl (formerly cr); Ropinirole/l-dopa; | [2] D00784 D00784
D08489 D08489 💬 |
[3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [4] 2 , 6 , 74, 309 💬 |
117 | Scopolamine | Scopolamine [2] Scopolamine; Scopolamine, atropine, edaravone and dexmedetomidine; | [1] D00138 D00138 💬 |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
002 [1] 2 💬 |
118 | Serine | D-serine [4] D-serine; D-serine (~2g/day); L-serine; Serine; | [1] D00016 D00016 💬 |
- |
- |
002 [3] 2 , 6 , 86 💬 |
119 | Serotonin | Selective serotonin uptake inhibitors (ssri) [2] Selective serotonin uptake inhibitors (ssri); Serotonin; | - |
- |
- |
002 [3] 2 , 96, 97 💬 |
120 | Sirolimus | Rapamycin, sirolimus [22] Rapamycin, sirolimus; Sirolimus; Sirolimus (formerly known as rapamycin); Sirolimus (study drug)+ace inhibitor + statin; Sirolimus 0,1% crème; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 1mg/ml; Sirolimus 2 mg; Sirolimus 2%; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sirolimus ointment; Sirolimus oral liquid product 1mg/ml; Sirolimus oral product; Sirolimus, 2%; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Tavt-18 (sirolimus); Temsirolimus; Temsirolimus tablets; Topical 0.1% sirolimus; | [1] D00753 D00753 💬 |
[1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [40] 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
121 | Somatotropin | Recombinant human somatotropin [3] Recombinant human somatotropin; Somatotropin; Somatotropine; | [1] D02691 D02691 💬 |
[1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
122 | Sulfate ion | - | - |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
123 | Sulpiride | - | [2] D01226 D01226
D08549 D08549 💬 |
[1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [5] 2 , 6 , 17, 46, 70 💬 |
124 | Tacrolimus | Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf [17] Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Interferon beta-1b and tacrolimus; Lcp-tacro (tacrolimus); Rectal tacrolimus; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); Tacrolimus; Tacrolimus (advagraf); Tacrolimus (prograf®); Tacrolimus (tacro); Tacrolimus and mmf; Tacrolimus capsule; Tacrolimus capsule (low-dose); Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus prolonged-release hard capsules; Tacrolimus tablets; Tacrolimus with methotrexate; | [2] D00107 D00107
D08556 D08556 💬 |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
125 | Talampanel | Talampanel [1] Talampanel; | [1] D02696 D02696 💬 |
[4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [2] 2 , 6 💬 |
126 | Tamoxifen | Tamoxifen [4] Tamoxifen; Tamoxifen 20mg hexal® filmtabletten; Tamoxifen 40 mg daily for one year; Tamoxifen citrate; | [2] D00966 D00966
D08559 D08559 💬 |
[2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 [4] 2 , 86, 113, 227 💬 |
127 | Tauroursodeoxycholic acid | Tauroursodeoxycholic acid [3] Tauroursodeoxycholic acid; Tauroursodeoxycholic acid (tudca); Tauroursodeoxycholic acid capsules; | [1] D11836 D11836 💬 |
- |
- |
002 [4] 2 , 13, 93, 299 💬 |
128 | Tenofovir | Emtricitabine (ftc)/tenofovir disoproxil (tdf) [10] Emtricitabine (ftc)/tenofovir disoproxil (tdf); Emtricitabine/tenofovir; Tenofovir; Tenofovir (tdf) and emtricitabine (ftc); Tenofovir alafenamide; Tenofovir alafenamide (taf); Tenofovir df; Tenofovir disoproxil; Tenofovir disoproxil fumarate; Tenofovir-emtricitabine; | [1] D06074 D06074 💬 |
- |
- |
002 [5] 2 , 25, 93, 265, 325 💬 |
129 | Tenofovir alafenamide | Tenofovir alafenamide [2] Tenofovir alafenamide; Tenofovir alafenamide (taf); | [1] D10428 D10428 💬 |
- |
- |
002 [1] 2 💬 |
130 | Testosterone | Androgel 10 grams of gel containing 100 mg of testosterone [13] Androgel 10 grams of gel containing 100 mg of testosterone; Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection; Procedure: testosterone injection; Sustanon (testosterone); Testosterone; Testosterone decanoate; Testosterone enanthate; Testosterone isocaproate; Testosterone phenylpropionate; Testosterone plus somatropin; Testosterone propionate; Testosterone undecanoate; Transdermal testosterone gel; | [6] D00075 D00075
D00957 D00957
D00958 D00958
D00959 D00959
D06085 D06085
D06087 D06087 💬 |
[1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 [8] 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
131 | Thalidomide | Fpf 300 (thalidomide) [10] Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide; Thalidomide (drug); Thalidomide 100mg; Thalidomide 150mg; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide celgene*28cps 50mg; Thalidomide pharmion; Thalidomide, cyclophosphamide and prednisone; | [1] D00754 D00754 💬 |
[1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
132 | Tirasemtiv | Tirasemtiv [1] Tirasemtiv; | [1] D10327 D10327 💬 |
- |
- |
002 [1] 2 💬 |
133 | Tocilizumab | Abatacept, rituximab or tocilizumab [39] Abatacept, rituximab or tocilizumab; Adalimuab, etanercept, tocilizumab, or abatacept; Corticoids+ tocilizumab 8mg/kg/4 weeks; Decrease tocilizumab, abatacept; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Inn-tocilizumab; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab; Tocilizumab (actemra or roactemra); Tocilizumab (actemra); Tocilizumab (actemra®); Tocilizumab (mra-sc); Tocilizumab (tcz); Tocilizumab + glucocorticoids (gcs); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab 162mg/0.9ml sc pfs sc; Tocilizumab 162mg/0.9ml syringe sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab and iv steroids combination; Tocilizumab infusion roacemtra (eu); Tocilizumab injection; Tocilizumab iv; Tocilizumab plus methotrexate; Tocilizumab prefilled syringe; Tocilizumab roche; Tocilizumab sc; Tocilizumab sc 162 mg/0.9 ml disposable auto-injector (ai); Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs); Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Tocilizumab treatment; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; | [1] D02596 D02596 💬 |
[1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
134 | Trametinib | Trametinib [5] Trametinib; Trametinib (0.5 mg); Trametinib (1 mg); Trametinib (2 mg); Trametinib tablet; | [1] D10175 D10175 💬 |
[2] MAP2K1, MAP2K2 💬 |
Acute myeloid leukemia [87] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
002 [4] 2 , 34, 279, 280 💬 |
135 | Trazodone | Trazodone [2] Trazodone; Trazodone hydrochloride oral solution; | [2] D00820 D00820
D08626 D08626 💬 |
[4] HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
002 [1] 2 💬 |
136 | Tretinoin | Pioglitazone and tretinoin [3] Pioglitazone and tretinoin; Tretinoin; Tretinoin and pioglitazone hcl; | [1] D00094 D00094 💬 |
[3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 [5] 2 , 63, 75, 94, 231 💬 |
137 | Triheptanoin | Triheptanoin [5] Triheptanoin; Triheptanoin / triheptanoina; Triheptanoin 1g/kg/day; Triheptanoin oil; Triheptanoina; | [1] D11465 D11465 💬 |
- |
- |
002 [9] 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
138 | TRO19622 | Olesoxime (tro19622) [2] Olesoxime (tro19622); Tro19622; | - |
- |
- |
002 [3] 2 , 3 , 13 💬 |
139 | Ubidecarenone | - | [1] D01065 D01065 💬 |
- |
- |
002 [13] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
140 | Umbilical Cord Blood Hematopoietic Stem Cells | - | - |
- |
- |
002 [2] 2 , 6 💬 |
141 | Valproic acid | Valproic acid [3] Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine; | [1] D00399 D00399 💬 |
[7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [16] 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬 |
142 | Verdiperstat | Verdiperstat [1] Verdiperstat; | [1] D11684 D11684 💬 |
[1] MPO 💬 |
Acute myeloid leukemia [5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer |
002 [2] 2 , 17 💬 |
143 | Vitamin E | Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) [9] Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e); Coenzyme q10 with vitamin e; Omega-3 and vitamin e supplementation; Vitamin c 10mg/kg vitamin e 10 mg/kg; Vitamin e; Vitamin e - tgps; Vitamin e 800iu; Vitamin e supplement; Vitamin e/selenium; | [1] D02331 D02331 💬 |
- |
- |
002 [12] 2 , 6 , 13, 20, 46, 49, 90, 96, 97, 206, 299, 317 💬 |
144 | Water | 15 o water [31] 15 o water; 15-o labeled water; 5% glucose water solution; Behavioral: diet and water adjustment; Behavioral: water tracking; Cholecalciferol concentrate (water-dispersible form); Device: manual toothbrush and water flosser (philips sonicare airfloss); Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss); Dextrose, 5% in water; High water intake; Lactose in water; Other: ad libitum water intake; Other: dead sea solar and water treatment; Other: dextrose water 5%; Other: exercise followed cold water immersion; Other: harkány medicinal water; Other: high water intake; Other: potable water; Other: water; Other: water prescription; Pl 12185/0002 & pl 12185/0005(water for injection); Procedure: water exercises; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; Sterile water; Sterile water for injection; Sterilised water for injections; Water; Water for injection; Water for injections; Water for injections, ep; | [1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
145 | Zilucoplan | Zilucoplan [2] Zilucoplan; Zilucoplan (ra101495); | - |
- |
- |
002 [3] 2 , 11, 62 💬 |
146 | Zinc | Zinc [6] Zinc; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zinc and copper; Zinc gluconate; | - |
- |
- |
002 [4] 2 , 113, 171, 299 💬 |